Clinical trial
Join the Sooma FDA clinical trial mailing list
Sooma is launching a pivotal FDA clinical trial to evaluate the effectiveness of our transcranial direct current stimulation (tDCS) system as an at-home treatment for Major Depressive Disorder (MDD) in the United States.
Stay updated on the trial.
Be among the first to know when recruitment begins and other crucial updates. Sign up today through the form below.